• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, July 10, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Nanoaggregation on command

Bioengineer by Bioengineer
June 28, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A combination of natural microtubules and synthetic macrocyclic receptors allows for the light-controlled, reversible aggregation of the microtubules into larger nanostructures. As Chinese scientists have reported in the journal Angewandte Chemie, when in a cellular environment these aggregated microtubules can also change cell morphology, causing cell death. The researchers hope to learn more about diseases caused by the improper aggregation of proteins.

In nature, the aggregation of molecules into superstructures plays an important role. Dynamic microtubules are protein filaments that combine with other components to form the cytoskeletons of our cells. During the cell cycle, microtubules constantly assemble and disassemble. Scientists from Nankai University and the Collaborative Innovation Center of Chemical Science and Engineering (Tianjin, China) conceived of the idea to combine microtubules into larger supramolecular aggregates using synthetic "receptors". In this way they hoped to produce innovative biomaterials and gain new knowledge about biological aggregation processes.

To attach the synthetic receptors to the microtubules, the team working with Yu Liu chose a cancer drug called paclitaxel. This molecule binds to microtubules and blocks deconstruction of the cytoskeleton, stopping cell division and causing cell death. As a receptor, the researchers chose a large cup-shaped molecule from the cyclodextrin family. These macrocyclic molecules can incorporate other molecules as "guests" in their large cavities. In this case the guest is an arylazopyrazole (AAP), a molecule with two aromatic rings bridged by a nitrogen-nitrogen double bond. The molecule can take one of two forms: a bent cisĀ­ form and a straight trans form. Only the straight version fits into the cyclodextrin "cup". The clever trick here is that, by using light of two different wavelengths, the AAP can be switched back and forth between its two forms at will.

The researchers used paclitaxel as a connector to attach "cups" and their "guests" to microtubules. Irradiation with visible and UV light switches the microtubules between an aggregated and non-aggregated form, respectively, as demonstrated by spectroscopic and microscopic examination. The aggregates take on a broad range of morphological variations, ranging from nanofibers to nanoribbons and nanoparticles of different sizes.

It is particularly interesting that the aggregation of the microtubules can also be triggered within cells. This causes the cells to shrink and die, which demonstrates that the cytotoxic effect of paclitaxel can be increased significantly.

The researchers hope that their approach will increase our understanding of the processes involved in physiological and pathological protein nanoassembly, and could create new prospects in the treatment of diseases caused by the improper aggregation of proteins.

###

About the Author

Dr. Yu Liu is a full professor in the College of Chemistry of Nankai University. His research focuses on macrocycle-based molecular recognition and assembly in supramolecular chemistry. He was the recipient of the National Natural Science Award, Second Prize, in 2010.

http://enstd.nankai.edu.cn/2017/1017/c6189a75401/page.htm

Media Contact

Mario Mueller
[email protected]

http://newsroom.wiley.com/

http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1521-3773/homepage/press/201819press.html

Related Journal Article

http://dx.doi.org/10.1002/anie.201804620

Share12Tweet8Share2ShareShareShare2

Related Posts

USF Study Urges New Approaches to Prevent Substance Misuse in America

July 10, 2026

Engineered Zwitterion Nanodelivery Enables Precise Brain Metastases Targeting

July 9, 2026

New Winn CIPP Cohort Launched by Pharma and Academic Coalition

July 9, 2026

Caloric Restriction Enhances Blood Sugar Control Through Adiponectin–Ceramide Pathway

July 9, 2026
Please login to join discussion

POPULAR NEWS

  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15
  • KTU Researchers Explore Ultrasound’s Role in Enhancing Blood Flow Beyond Diagnostics

    53 shares
    Share 21 Tweet 13
  • é«˜é½¢č€…ć®éŖØē²—é¬†ē—‡ę²»ē™‚ć®ęŒē¶šę€§ęÆ”č¼ƒ

    51 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

USF Study Urges New Approaches to Prevent Substance Misuse in America

Unmedicated Depressed Women Show Reduced Heat Tolerance Compared to SSRI Users

Engineered Zwitterion Nanodelivery Enables Precise Brain Metastases Targeting

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 84 other subscribers
  • Contact Us

Bioengineer.org Ā© Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org Ā© Copyright 2023 All Rights Reserved.